Seminars
Apr 2, 2026
Mechanistic insights into angiogenesis in diseases and novel drug discovery
Speaker: Professor Yihai Cao
Professor, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
School of Biomedical Sciences cordially invites you to join the following seminar:
Date: 2 April 2026 (Thursday)
Time: 4:00 pm – 5:00 pm
Venue: Lecture Theatre 2, G/F, William M.W. Mong Block, 21 Sassoon Road
Host: Professor Zhongjun Zhou
Biography
Vascular biology and mechanisms underlying blood vessels in various diseases. Prof Yihai Cao, originally trained as a clinician, received his PhD at the Karolinska Institutet and postdoctoral training at the Harvard Medical School, is a leading expert in vascular biology and angiogenesis, particularly specializing in translational research from basic research toward clinical applications. Prof Cao has been working in the field of vascular biology for 40 years and has made both conceptual and experimental discoveries that has changed our knowledge in understanding biology and diseases, including but not limited to, cerebrocardiovascular diseases, cancer, metabolic diseases, eye diseases, and inflammatory diseases. and have paved new avenues for drug development. Prof Cao is a panel member of RGC, Chinese Academy of Engineering, Academia Europaea, and National Academy of Inventors.
Abstract
Mechanistic investigation of the molecular events during blood vessel formation, growth and homeostasis under physiological and pathological settings, such as embryogenesis, aging, cancer, CVD, diabetes, ophthalmologic disorders, and inflammatory diseases, etc., are critical to our understanding of various developmental processes and the pathogenesis of diseases, in particular defining targets for drug development and clinical intervention.
All are welcome.
New Releases
Mar 9, 2026
HKUMed demonstrates that 'cloaked' and safe human stem cells work, paving the way for off-the-shelf transplants without immune rejection
Feb 11, 2026
HKUMed School of Biomedical Sciences and Merck Pharmaceutical (Hong Kong) sign MoU to advance biomedical education and talent development
Nov 25, 2025
HKUMed cracks gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases
Nov 6, 2025